Jag Capital Management’s Bio-Techne TECH Stock Holding History

Jag Capital Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,836	Closed	-$207K	–	239
2021 Q2	$207K	Buy	+1,836	New	+$193K	0.02%	220

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Jag Capital Management's TECH Position: Q3 2021 in Review

Jag Capital Management sold out of Bio-Techne (TECH) in Q3 2021, closing a stake of 1,836 shares — an estimated $207K sold.

Jag Capital Management first reported a position in TECH in Q2 2021 and held it in 1 quarter. The position peaked at $207K in Q2 2021. 565 funds tracked by Wall St. Rank hold TECH as of Q3 2021.

Jag Capital Management reported no remaining Bio-Techne position as of Q3 2021 after selling out during the quarter.
Jag Capital Management sold 1,836 Bio-Techne shares in Q3 2021, an estimated $207K.
Jag Capital Management first reported a position in Bio-Techne in Q2 2021 and held it in 1 quarter.
Jag Capital Management's Bio-Techne position peaked at $207K in Q2 2021.
565 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2021.

Based on Jag Capital Management's 13F filing for Q3 2021, filed 21 Oct 2021.